| Company/Division name | Hovione |
| Parent company | Hovione Limited |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2026 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 100 |
| Country(ies) from which reshored: | Portugal |
| City reshored to: | East Windsor |
| State(s) reshored to: | NJ |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | API - Particle - Drug Products |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market, Under-utilized capacity |
